María Natalia Gandur Quiroga: Study on Gleason Grade Group 1 Prostate Cancer reveals key findings
María Natalia Gandur Quiroga shared a post on X about a recent paper by Anthony V. D’Amico et al. published in Science Direct, commenting:
“Recent study on Gleason Grade Group 1 Prostate Cancer reveals key findings:
- PPB >50% and PSA >20 ng/ml are significantly associated with higher risk of adverse pathology.
- Patients with these factors have higher risk of early PSA failure and prostate cancer-specific mortality.
- Maintaining the ‘cancer’ classification for GGG 1 with PPB >50% or PSA >20 ng/ml and considering rebiopsy is recommended to identify unsampled high-grade disease.”
“Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate Cancer”
Authors: Derya Tilki, Ming-Hui Chen, Hartwig Huland, Markus Graefen, Anthony V. D’Amico.
Source: María Natalia Gandur Quiroga/X
Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Ángel H. Roffo Oncology Institute in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies.
Her research focuses on clinical trials with aim of improving the treatment of patients with urologic tumors. She is an active member of the European Association for Cancer Research, the Argentinian Medical Association and the American Society of Clinical Oncology.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023